Identification of hm13 as a prognostic indicator and a predictive biomarker for immunotherapy in hepatocellular carcinoma

HIGHLIGHTS

• who: Genhao Zhang from the The Shanghai Institute of Cells (Chinese Academy of Science, Shanghai, China) provided cell lines (HepG2, Hep B, HuH7, and MHCC L)Cells were grown in have published the Article: Identification of HM13 as a prognostic indicator and a predictive biomarker for immunotherapy in hepatocellular carcinoma, in the Journal: (JOURNAL) of 30/03/2022
• what: Considering that clinical samples of LGG were difficult to collect, and the authors had collected clinical samples of HCC and normal tissues, subsequently, the authors focused on the role of HM13 in HCC. Interestingly, the focus . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.